Can Boston Scientific Ever Get It Right?

And so continues my long love affair with not liking Boston Scientific (BSX).

http://stocks.investopedia.com/stock-analysis/2010/Can-Boston-Scientific-Ever-Get-It-Right-BSX-STJ-MDT-ABT-VOLC0430.aspx

It is only fair to state that from the beginning that I have been a long-term skeptic and critic of Boston Scientific (NYSE:BSX), going back to the late 1990's when I covered the stock as a junior research analyst. Ever since, my skepticism has been rewarded as the company has made missteps and blunders too numerous to recount here. 

With a relatively new CEO at the helm and earnings fresh on the tape, it's worthwhile to take another look at this well-known name to see if anything has changed for the better.  

For the remainder of the article: 
  http://stocks.investopedia.com/stock-analysis/2010/Can-Boston-Scientific-Ever-Get-It-Right-BSX-STJ-MDT-ABT-VOLC0430.aspx

Will St. Jude Keep The Beat? (STJ, MDT, BSX)

Sorry for the slight delay, folks.

Here's the latest that I've written for Investopedia.

http://community.investopedia.com/news/IA/2008/Will-St.-Jude-Keep-The-Beat-STJ-MDT-BSX1020.aspx.

ss